The annual show for the embedded electronics supply chain showcased many innovations in edge AI and connected, intelligent systems that can perceive and act in real time.
AstraZeneca's push into CAR-T therapies for cancer has continued with an agreement to take full control of C-CAR031, an anti-GPC3 therapy for solid tumours, from AbelZeta. In the latest development, ...